GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » Total Liabilities

ViaDerma (ViaDerma) Total Liabilities : $10.74 Mil (As of Jun. 2012)


View and export this data going back to 2008. Start your Free Trial

What is ViaDerma Total Liabilities?

ViaDerma's Total Liabilities for the quarter that ended in Jun. 2012 was $10.74 Mil.

ViaDerma's quarterly Total Liabilities increased from Dec. 2011 ($9.09 Mil) to Mar. 2012 ($10.81 Mil) but then declined from Mar. 2012 ($10.81 Mil) to Jun. 2012 ($10.74 Mil).

ViaDerma's annual Total Liabilities increased from Dec. 2009 ($6.60 Mil) to Dec. 2010 ($6.87 Mil) and increased from Dec. 2010 ($6.87 Mil) to Dec. 2011 ($9.09 Mil).


ViaDerma Total Liabilities Historical Data

The historical data trend for ViaDerma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma Total Liabilities Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
Total Liabilities
- 4.30 6.60 6.87 9.09

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.58 10.28 9.09 10.81 10.74

ViaDerma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ViaDerma's Total Liabilities for the fiscal year that ended in Dec. 2011 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.765+(3.32+0.0010000000000008
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=9.09

Total Liabilities=Total Assets (A: Dec. 2011 )-Total Equity (A: Dec. 2011 )
=42.645-33.56
=9.09

ViaDerma's Total Liabilities for the quarter that ended in Jun. 2012 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=7.872+(2.862+0.00099999999999945
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=10.74

Total Liabilities=Total Assets (Q: Jun. 2012 )-Total Equity (Q: Jun. 2012 )
=45.832-35.098
=10.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ViaDerma Total Liabilities Related Terms

Thank you for viewing the detailed overview of ViaDerma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


ViaDerma (ViaDerma) Business Description

Traded in Other Exchanges
N/A
Address
4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.